Results 91 to 100 of about 1,391,718 (154)

Methodological guidelines for P2X receptor assays and data interpretation. [PDF]

Cell Death Dis
Gorecki DC, Adinolfi E, Adriouch S, Coutinho-Silva R, Engel T, Gölöncsér F, Haag F, Illes P, Jacobson KA, Koch-Nolte F, Mansoor SE, Matute C, Melino G, Novak I, Pegoraro A, Pelegrin P, Piacentini M, Robson SC, Rumney RMH, Seman M, Sluyter R, Sperlagh B, Tang Y, Tarantini M, Ulrich H, Vouret-Craviari V, Ye Q, Yegutkin GG, Verkhratsky A.   +28 more
europepmc   +1 more source

ATP and major affective disorders: the involvement of P2X receptors in pathophysiology. [PDF]

Purinergic Signal
Mattova S, Simko P, Colzi E, Stammova E, Urbanska N, Grigoroiu-Serbanescu M, Coppi E, Kiskova-Simkova T.   +7 more
europepmc   +1 more source

From metabolic intermediary to neurotransmitter: purinergic signaling in neurophysiology and vulnerability of brain circuits. [PDF]

Biosci Rep
Marques LB, de Carvalho A, Souza RLLDS, Viero FT, Britto LRG, Ulrich H.   +5 more
europepmc   +1 more source

P2X receptors and lipids interact to modulate inflammation. [PDF]

J Lipid Res
Vidal VN, Pereira TC, Teixeira GP, Rocha L, Faria RX.   +4 more
europepmc   +1 more source

ATP-related purinergic signaling via P2Y12 contributes to airway epithelial barrier integrity. [PDF]

BMC Mol Cell Biol
Tsuya K, Maruoka S, Okamoto S, Shikano S, Ujike M, Yamada S, Kurosawa Y, Mizumura K, Kozu Y, Gon Y.   +9 more
europepmc   +1 more source

Phenolic compounds and chemotherapeutic agents differentially regulate P2X receptor subtypes in malignant melanoma. [PDF]

Purinergic Signal
Sen S, Celik S.
europepmc   +1 more source

Liver Fibrosis and Purinergic Signaling: Autocrine-Paracrine Role of ATP in Liver Damage. [PDF]

Int J Mol Sci
Ramos-Rosillo BV, Mata-Martínez E, Díaz-Muñoz M, Vázquez-Cuevas FG.   +3 more
europepmc   +1 more source

P2X7 receptor-mediated IL-1β release by human brain tissue: the impact of CNS-penetrant potential therapeutics. [PDF]

Brain
Cowley J, Harrison N, Pegg A, Chan H, Li Z, Kaur A, Welsh E, Brewin A, Yam-Puc JC, Fensome G, Broome E, Morano IM, Jinks E, Grafton G, Cooper AJ, Ahmed Z, Stevens AR, Anderson FG, Wykes V, Chelvarajah R, Tsermoulas G, Ughratdar I, Zisakis A, O'Halloran PJ, Davies DJ, Land T, Chowdhury YA, Sher Z, Yakoub KM, Bergin C, Galloway L, Upthegrove R, Brady CA, Gordon J, Qureshi O, Belli A, Barnes NM.   +36 more
europepmc   +1 more source

Editorial: Advancements in P2X7 antagonists: from mechanistic insights to therapeutic applications. [PDF]

Front Pharmacol
Ferreira NCDS, Soares Bezerra RJ, Bisaggio RDC.   +2 more
europepmc   +1 more source

Effects on mouse melanoma and immune cells of P2X7 receptor positive allosterism by clemastine. [PDF]

Purinergic Signal
Thorstenberg ML, Falzoni S, Garcia-Jacobo RE, Bergamin LS, Tarantini M, Conversano G, Pegoraro A, Di Virgilio F, Adinolfi E, Giuliani AL.   +9 more
europepmc   +1 more source